Nektar Therapeutics Reports Third Quarter 2023 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2023. Cash and investments in...

Related Keywords

Alabama ,United States ,San Francisco ,California ,Vivian Wu ,David Rosen ,Cellular Biomedicine Group Inc ,Cellular Biomedicine Group ,Nektar Therapeutics ,European Academy Of Dermatology ,Exchange Commission On ,Duke Cancer Institute ,Recent Business ,Duke Cancer ,Eczema Area ,Severity Index ,Validated Investigator Global Assessment ,Body Surface Area ,Itch Numeric Rating Scale ,Daily Life Quality Index ,Patient Oriented Eczema Measure ,Discuss Third Quarter ,Home Page ,Nektar Earnings Call ,Annual Report ,Exchange Commission ,